New issuance markets in September finished strong, ranking second in number of deals per month in 2013, with 21 debuts raising $3.6B, slightly behind May’s 24 IPOs and $6.0B. The Technology and Healthcare sectors saw an overwhelming majority of the deals, accounting for 76% of the activity ($2.6B). This is a huge improvement as the year-ago period saw only two Tech deals for $221.8M. September also saw a handful of globally domiciled deals including Israel-based Enzymotec ($71.0M), Montage Technology Group Ltd. ($71.0M) from China and Controladora Vuela Compania de Aviacion, S.A.B. de C.V. ($271.8M) from Mexico.